Monitoring interactions and dynamics of endogenous beta-catenin with intracellular nanobodies in living cells

Molecular and Cellular Proteomics

Volumn 14, Issue 3, 2015, Pages 707-723

  Traenkle, Bjoern ^a   Emele, Felix ^a   Anton, Roman ^a   Poetz, Oliver ^a   Haeussler, Ragna S ^a   Maier, Julia ^a   Kaiser, Philipp D ^a   Scholz, Armin M ^b   Nueske, Stefan ^b   Buchfellner, Andrea ^c   Romer, Tina ^c   Rothbauer, Ulrich ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c CHROMOTEK GMBH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; MULTIPROTEIN COMPLEX; NANOBODY; UVOMORULIN;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ANIMAL EXPERIMENT; ARTICLE; ARTIODACTYLA; CARBOXY TERMINAL SEQUENCE; CELL VIABILITY; CELLULAR DISTRIBUTION; CYTOPLASM; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITOPE MAPPING; FLUORESCENCE MICROSCOPY; GEL PERMEATION CHROMATOGRAPHY; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMOBILIZED METAL AFFINITY CHROMATOGRAPHY; IMMUNOASSAY; IMMUNOBLOTTING; IMMUNOPRECIPITATION; LUCIFERASE ASSAY; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; RESAZURIN ASSAY; SURFACE PLASMON RESONANCE; TRANSCRIPTION INITIATION; VICUGNA PACOS; WESTERN BLOTTING; AFFINITY CHROMATOGRAPHY; ANIMAL; BINDING SITE; CELL LINE; CELL NUCLEUS; CHEMISTRY; FLUORESCENT ANTIBODY TECHNIQUE; HCT116 CELL LINE; HEK293 CELL LINE; HELA CELL LINE; IMMUNOLOGY; METABOLISM; NEW WORLD CAMELID; PROCEDURES; PROTEIN TRANSPORT;

CAMELIDAE;

ANIMALS; BETA CATENIN; BINDING SITES; CAMELIDS, NEW WORLD; CELL LINE; CELL NUCLEUS; CHROMATOGRAPHY, AFFINITY; CYTOPLASM; FLUORESCENT ANTIBODY TECHNIQUE; HCT116 CELLS; HEK293 CELLS; HELA CELLS; HUMANS; PROTEIN TRANSPORT; SINGLE-DOMAIN ANTIBODIES;

EID: 84924309994     PISSN: 15359476     EISSN: 15359484     Source Type: Journal    
DOI: 10.1074/mcp.M114.044016     Document Type: Article

References (73)

1. Takeichi, M. (1995) Morphogenetic roles of classic cadherins. Curr. Opin. Cell Biol. 7, 619-627
2. Korinek, V., Barker, N., Morin, P. J., van Wichen, D., de Weger, R., Kinzler, K. W., Vogelstein, B., and Clevers, H. (1997) Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/-colon carcinoma. Science 275, 1784-1787
3. Behrens, J., and Lustig, B. (2004) The Wnt connection to tumorigenesis. Int. J. Dev. Biol. 48, 477-487
4. Aberle, H., Bauer, A., Stappert, J., Kispert, A., and Kemler, R. (1997) beta-catenin is a target for the ubiquitin-proteasome pathway. EMBO J. 16, 3797-3804
5. Hart, M., Concordet, J. P., Lassot, I., Albert, I., del los Santos, R., Durand, H., Perret, C., Rubinfeld, B., Margottin, F., Benarous, R., and Polakis, P. (1999) The F-box protein beta-TrCP associates with phosphorylated beta-catenin and regulates its activity in the cell. Curr. Biol. 9, 207-210
6. Marikawa, Y., and Elinson, R. P. (1998) beta-TrCP is a negative regulator of Wnt/beta-catenin signaling pathway and dorsal axis formation in Xenopus embryos. Mech. Dev. 77, 75-80
7. Liu, C., Li, Y., Semenov, M., Han, C., Baeg, G. H., Tan, Y., Zhang, Z., Lin, X., and He, X. (2002) Control of beta-catenin phosphorylation/degradation by a dual-kinase mechanism. Cell 108, 837-847
8. Huang, H., and He, X. (2008) Wnt/beta-catenin signaling: new (and old) players and new insights. Curr. Opin. Cell Biol. 20, 119-125
9. Kimelman, D., and Xu, W. (2006) beta-catenin destruction complex: insights and questions from a structural perspective. Oncogene 25, 7482-7491
10. Bilic, J., Huang, Y. L., Davidson, G., Zimmermann, T., Cruciat, C. M., Bienz, M., and Niehrs, C. (2007) Wnt induces LRP6 signalosomes and promotes dishevelled-dependent LRP6 phosphorylation. Science 316, 1619-1622
11. MacDonald, B. T., Tamai, K., and He, X. (2009) Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev. Cell 17, 9-26
12. Li, V. S., Ng, S. S., Boersema, P. J., Low, T. Y., Karthaus, W. R., Gerlach, J. P., Mohammed, S., Heck, A. J., Maurice, M. M., Mahmoudi, T., and Clevers, H. (2012) Wnt signaling through inhibition of beta-catenin degradation in an intact Axin1 complex. Cell 149, 1245-1256
13. Nusse, R. (1999) WNT targets. Repression and activation. Trends Genet. 15, 1-3
14. Staal, F. J., and Clevers, H. (2000) Tcf/Lef transcription factors during T-cell development: unique and overlapping functions. Hematol. J. 1, 3-6
15. Clevers, H. (2006) Wnt/beta-catenin signaling in development and disease. Cell 127, 469-480
16. Valenta, T., Hausmann, G., and Basler, K. (2012) The many faces and functions of beta-catenin. EMBO J. 31, 2714-2736
17. Mosimann, C., Hausmann, G., and Basler, K. (2009) Beta-catenin hits chromatin: regulation of Wnt target gene activation. Nat. Rev. Mol. Cell Biol. 10, 276-286
18. Kinzler, K. W., and Vogelstein, B. (1996) Lessons from hereditary colorectal cancer. Cell 87, 159-170
19. Morin, P. J., Sparks, A. B., Korinek, V., Barker, N., Clevers, H., Vogelstein, B., and Kinzler, K. W. (1997) Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science 275, 1787-1790
20. Logan, C. Y., and Nusse, R. (2004) The Wnt signaling pathway in development and disease. Annu. Rev. Cell Dev. Biol. 20, 781-810
21. Reya, T., and Clevers, H. (2005) Wnt signaling in stem cells and cancer. Nature 434, 843-850
22. Miyoshi, K., and Hennighausen, L. (2003) Beta-catenin: a transforming actor on many stages. Breast Cancer Res. 5, 63-68
23. Kahn, M. (2014) Can we safely target the WNT pathway? Nat. Rev. Drug Discov. 13, 513-532
24. Damalas, A., Ben-Ze'ev, A., Simcha, I., Shtutman, M., Leal, J. F., Zhurinsky, J., Geiger, B., and Oren, M. (1999) Excess beta-catenin promotes accumulation of transcriptionally active p53. EMBO J. 18, 3054-3063
25. Giannini, A. L., Vivanco, M. M., and Kypta, R. M. (2000) Analysis of betacatenin aggregation and localization using GFP fusion proteins: nuclear import of alpha-catenin by the beta-catenin/Tcf complex. Exp. Cell Res. 255, 207-220
26. Krieghoff, E., Behrens, J., and Mayr, B. (2006) Nucleo-cytoplasmic distribution of beta-catenin is regulated by retention. J. Cell Sci. 119, 1453-1463
27. Johnson, M., Sharma, M., Jamieson, C., Henderson, J. M., Mok, M. T., Bendall, L., and Henderson, B. R. (2009) Regulation of beta-catenin trafficking to the membrane in living cells. Cell. Signal. 21, 339-348
28. Hamers-Casterman, C., Atarhouch, T., Muyldermans, S., Robinson, G., Hamers, C., Songa, E. B., Bendahman, N., and Hamers, R. (1993) Naturally occurring antibodies devoid of light chains. Nature 363, 446-448
29. Muyldermans, S., Baral, T. N., Retamozzo, V. C., De Baetselier, P., De Genst, E., Kinne, J., Leonhardt, H., Magez, S., Nguyen, V. K., Revets, H., Rothbauer, U., Stijlemans, B., Tillib, S., Wernery, U., Wyns, L., Hassanzadeh-Ghassabeh, G., and Saerens, D. (2009) Camelid immunoglobulins and nanobody technology. Vet. Immunol. Immunopathol. 128, 178-183
30. Muyldermans, S. (2013) Nanobodies: natural single-domain antibodies. Annu. Rev. Biochem. 82, 775-797
31. Rothbauer, U., Zolghadr, K., Tillib, S., Nowak, D., Schermelleh, L., Gahl, A., Backmann, N., Conrath, K., Muyldermans, S., Cardoso, M. C., and Leonhardt, H. (2006) Targeting and tracing antigens in live cells with fluorescent nanobodies. Nat. Methods 3, 887-889
32. Zolghadr, K., Gregor, J., Leonhardt, H., and Rothbauer, U. (2012) Case study on live cell apoptosis-assay using lamin-chromobody cell-lines for high-content analysis. Methods Mol. Biol. 911, 569-575
33. Helma, J., Schmidthals, K., Lux, V., Nuske, S., Scholz, A. M., Krausslich, H. G., Rothbauer, U., and Leonhardt, H. (2012) Direct and dynamic detection of HIV-1 in living cells. PloS One 7, e50026
34. Arbabi Ghahroudi, M., Desmyter, A., Wyns, L., Hamers, R., and Muyldermans, S. (1997) Selection and identification of single domain antibody fragments from camel heavy-chain antibodies. FEBS Lett. 414, 521-526
35. Rothbauer, U., Zolghadr, K., Muyldermans, S., Schepers, A., Cardoso, M. C., and Leonhardt, H. (2008) A versatile nanotrap for biochemical and functional studies with fluorescent fusion proteins. Mol. Cell. Proteomics 7, 282-289
36. Aberle, H., Butz, S., Stappert, J., Weissig, H., Kemler, R., and Hoschuetzky, H. (1994) Assembly of the cadherin-catenin complex in vitro with recombinant proteins. J. Cell Sci. 107, 3655-3663
37. Luckert, K., Gotschel, F., Sorger, P. K., Hecht, A., Joos, T. O., and Potz, O. (2011) Snapshots of protein dynamics and post-translational modifications in one experiment-beta-catenin and its functions. Mol. Cell. Proteomics 10, M110 007377
38. Braeuning, A., Menzel, M., Kleinschnitz, E. M., Harada, N., Tamai, Y., Kohle, C., Buchmann, A., and Schwarz, M. (2007) Serum components and activated Ha-ras antagonize expression of perivenous marker genes stimulated by beta-catenin signaling in mouse hepatocytes. FEBS J. 274, 4766-4777
39. Zolghadr, K., Mortusewicz, O., Rothbauer, U., Kleinhans, R., Goehler, H., Wanker, E. E., Cardoso, M. C., and Leonhardt, H. (2008) A fluorescent two-hybrid assay for direct visualization of protein interactions in living cells. Mol. Cell. Proteomics 7, 2279-2287
40. Zolghadr, K., Rothbauer, U., and Leonhardt, H. (2012) The fluorescent two-hybrid (F2H) assay for direct analysis of protein-protein interactions in living cells. Methods Mol. Biol. 812, 275-282
41. Poetz, O., Luckert, K., Herget, T., and Joos, T. O. (2009) Microspherebased co-immunoprecipitation in multiplex. Anal. Biochem. 395, 244-248
42. Livak, K. J., and Schmittgen, T. D. (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25, 402-408
43. Kirchhofer, A., Helma, J., Schmidthals, K., Frauer, C., Cui, S., Karcher, A., Pellis, M., Muyldermans, S., Casas-Delucchi, C. S., Cardoso, M. C., Leonhardt, H., Hopfner, K. P., and Rothbauer, U. (2010) Modulation of protein properties in living cells using nanobodies. Nat. Struct. Mol. Biol. 17, 133-138
44. Xu, W., and Kimelman, D. (2007) Mechanistic insights from structural studies of beta-catenin and its binding partners. J. Cell Sci. 120, 3337-3344
45. Huber, A. H., Nelson, W. J., and Weis, W. I. (1997) Three-dimensional structure of the armadillo repeat region of beta-catenin. Cell 90, 871-882
46. Bauer, M., Chicca, A., Tamborrini, M., Eisen, D., Lerner, R., Lutz, B., Poetz, O., Pluschke, G., and Gertsch, J. (2012) Identification and quantification of a new family of peptide endocannabinoids (Pepcans) showing negative allosteric modulation at CB1 receptors. J. Biol. Chem. 287, 36944-36967
47. van Noort, M., Meeldijk, J., van der Zee, R., Destree, O., and Clevers, H. (2002) Wnt signaling controls the phosphorylation status of beta-catenin. J. Biol. Chem. 277, 17901-17905
48. Olivier-Van Stichelen, S., Dehennaut, V., Buzy, A., Zachayus, J. L., Guinez, C., Mir, A. M., El Yazidi-Belkoura, I., Copin, M. C., Boureme, D., Loyaux, D., Ferrara, P., and Lefebvre, T. (2014) O-GlcNAcylation stabilizes betacatenin through direct competition with phosphorylation at threonine 41. FASEB J. 28, 3325-3338
49. Bennett, C. N., Ross, S. E., Longo, K. A., Bajnok, L., Hemati, N., Johnson, K. W., Harrison, S. D., and MacDougald, O. A. (2002) Regulation of Wnt signaling during adipogenesis. J. Biol. Chem. 277, 30998-31004
50. Miller, J. R., and Moon, R. T. (1997) Analysis of the signaling activities of localization mutants of beta-catenin during axis specification in Xenopus. J. Cell Biol. 139, 229-243
51. Ilyas, M., Tomlinson, I. P., Rowan, A., Pignatelli, M., and Bodmer, W. F. (1997) Beta-catenin mutations in cell lines established from human colorectal cancers. Proc. Natl. Acad. Sci. U.S.A. 94, 10330-10334
52. Chetty, R., Serra, S., and Asa, S. L. (2008) Loss of membrane localization and aberrant nuclear E-cadherin expression correlates with invasion in pancreatic endocrine tumors. Am. J. Surg. Pathol. 32, 413-419
53. Ferber, E. C., Kajita, M., Wadlow, A., Tobiansky, L., Niessen, C., Ariga, H., Daniel, J., and Fujita, Y. (2008) A role for the cleaved cytoplasmic domain of E-cadherin in the nucleus. J. Biol. Chem. 283, 12691-12700
54. Burgess, A., Lorca, T., and Castro, A. (2012) Quantitative live imaging of endogenous DNA replication in mammalian cells. PloS One 7, e45726
55. Van Audenhove, I., Van Impe, K., Ruano-Gallego, D., De Clercq, S., De Muynck, K., Vanloo, B., Verstraete, H., Fernandez, L. A., and Gettemans, J. (2013) Mapping cytoskeletal protein function in cells by means of nanobodies. Cytoskeleton 70, 604-622
56. Behrens, J., von Kries, J. P., Kuhl, M., Bruhn, L., Wedlich, D., Grosschedl, R., and Birchmeier, W. (1996) Functional interaction of beta-catenin with the transcription factor LEF-1. Nature 382, 638-642
57. Huber, O., Korn, R., McLaughlin, J., Ohsugi, M., Herrmann, B. G., and Kemler, R. (1996) Nuclear localization of beta-catenin by interaction with transcription factor LEF-1. Mech. Dev. 59, 3-10
58. Monga, S. P., Mars, W. M., Pediaditakis, P., Bell, A., Mule, K., Bowen, W. C., Wang, X., Zarnegar, R., and Michalopoulos, G. K. (2002) Hepatocyte growth factor induces Wnt-independent nuclear translocation of beta-catenin after Met-beta-catenin dissociation in hepatocytes. Cancer Res. 62, 2064-2071
59. Okerlund, N. D., and Cheyette, B. N. (2011) Synaptic Wnt signaling-a contributor to major psychiatric disorders? J. Neurodev. Disorders 3, 162-174
60. Inestrosa, N. C., Montecinos-Oliva, C., and Fuenzalida, M. (2012) Wnt signaling: role in Alzheimer disease and schizophrenia. J. Neuroimmune Pharmacol. 7, 788-807
61. Schinner, S., Willenberg, H. S., Schott, M., and Scherbaum, W. A. (2009) Pathophysiological aspects of Wnt-signaling in endocrine disease. Eur. J. Endocrinol. 160, 731-737
62. Giles, R. H., van Es, J. H., and Clevers, H. (2003) Caught up in a Wnt storm: Wnt signaling in cancer. Biochim. Biophys. Acta 1653, 1-24
63. Cui, J., Jiang, W., Wang, S., Wang, L., and Xie, K. (2012) Role of Wnt/betacatenin signaling in drug resistance of pancreatic cancer. Curr. Pharm. Des. 18, 2464-2471
64. Mokkapati, S., Niopek, K., Huang, L., Cunniff, K. J., Ruteshouser, E. C., Finegold, M. J., and Huff, V. (2014) Catenin activation in a novel liver progenitor cell type is sufficient to cause hepatocellular carcinoma and hepatoblastoma. Cancer Res. 3275:2013
65. Santoro, A., Pannone, G., Papagerakis, S., McGuff, H. S., Cafarelli, B., Lepore, S., De Maria, S., Rubini, C., Mattoni, M., and Staibano, S. (2014) Beta-Catenin and Epithelial Tumors: A Study Based on 374 Oropharyngeal Cancers. BioMed Res. Int. 2014, 1-13
66. van Noort, M., Weerkamp, F., Clevers, H. C., and Staal, F. J. (2007) Wnt signaling and phosphorylation status of beta-catenin: importance of the correct antibody tools. Blood 110, 2778-2779
67. Fang, D., Hawke, D., Zheng, Y., Xia, Y., Meisenhelder, J., Nika, H., Mills, G. B., Kobayashi, R., Hunter, T., and Lu, Z. (2007) Phosphorylation of beta-catenin by AKT promotes beta-catenin transcriptional activity. J. Biol. Chem. 282, 11221-11229
68. Zhu, G., Wang, Y., Huang, B., Liang, J., Ding, Y., Xu, A., and Wu, W. (2012) A Rac1/PAK1 cascade controls beta-catenin activation in colon cancer cells. Oncogene 31, 1001-1012
69. Trinkle-Mulcahy, L., Boulon, S., Lam, Y. W., Urcia, R., Boisvert, F. M., Vandermoere, F., Morrice, N. A., Swift, S., Rothbauer, U., Leonhardt, H., and Lamond, A. (2008) Identifying specific protein interaction partners using quantitative mass spectrometry and bead proteomes. J. Cell Biol. 183, 223-239
70. Fridy, P. C., Li, Y., Keegan, S., Thompson, M. K., Nudelman, I., Scheid, J. F., Oeffinger, M., Nussenzweig, M. C., Fenyo, D., Chait, B. T., and Rout, M. P. (2014) A robust pipeline for rapid production of versatile nanobody repertoires. Nat. Methods 11, 1253-1260
71. Delanote, V., Vanloo, B., Catillon, M., Friederich, E., Vandekerckhove, J., and Gettemans, J. (2010) An alpaca single-domain antibody blocks filopodia formation by obstructing L-plastin-mediated F-actin bundling. FASEB J. 24, 105-118
72. Tan, C. W., Gardiner, B. S., Hirokawa, Y., Smith, D. W., and Burgess, A. W. (2014) Analysis of Wnt signaling beta-catenin spatial dynamics in HEK293T cells. BMC Sys. Biol. 8, 44
73. Sibler, A. P., Courtete, J., Muller, C. D., Zeder-Lutz, G., and Weiss, E. (2005) Extended half-life upon binding of destabilized intrabodies allows specific detection of antigen in mammalian cells. FEBS J. 272, 2878-2891